Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$8.56bn	136.58	n/a
MSBMesoblast	AU$2.02bn	n/a	n/a
OPTOpthea	AU$738.75m	n/a	n/a
CU6Clarity Pharmaceuticals	AU$721.82m	n/a	n/a
PYCPYC Therapeutics	AU$699.91m	n/a	n/a
IMMImmutep	AU$393.01m	n/a	n/a
DXBDimerix	AU$312.41m	n/a	n/a
CGSCogstate	AU$221.78m	19.73	n/a
RACRace Oncology	AU$205.85m	n/a	n/a
IMUImugene	AU$119.03m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$110.99m	n/a	n/a
SNTSyntara	AU$108.96m	n/a	n/a
AGNArgenica Therapeutics	AU$100.55m	n/a	n/a
ALAArovella Therapeutics	AU$81.57m	n/a	n/a
PEBPacific Edge	NZ$78.76m	n/a	n/a
ACWActinogen Medical	AU$65.79m	n/a	n/a
ATHAlterity Therapeutics	AU$63.84m	n/a	n/a
GD8GO-DX (Aust)	AU$61.94m	n/a	n/a
LTPLtr Pharma	AU$56.10m	n/a	n/a
PIQProteomics International Laboratories	AU$55.02m	n/a	n/a